Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Lymphoma 2Sclerosteosis 1Periodontitis 1Periodontal Diseases 1Osteoporosis, Postmenopausal 1Neoplasms 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Liver Cirrhosis 1Leukemia, Promyelocytic, Acute 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Lymphoma × Weights and Measures × Clear all
NCT03530969 2024-02-20

Geriatric Communication Skills Training Program for Oncology Clinicians

Memorial Sloan Kettering Cancer Center

Phase NA Completed
88 enrolled
GastrointestinalLymphoid

Gastrointestinal Neoplasms, Lymphoma

NCT03260855 2023-08-23

PResEnCE

University Hospital, Toulouse

Phase NA Completed
200 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡